These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35438133)

  • 1. Construction of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in thymic epithelial tumors.
    Su Y; Ou Y; Chen Y; Ma X
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35438133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
    Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
    World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNAs classifier to accurately predict the recurrence of thymic epithelial tumors.
    Su Y; Chen Y; Tian Z; Lu C; Chen L; Ma X
    Thorac Cancer; 2020 Jul; 11(7):1773-1783. PubMed ID: 32374079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence.
    Liu W; Yang HS; Zheng SY; Weng JH; Luo HH; Lei YY; Feng YF
    BMC Genomics; 2022 Sep; 23(1):656. PubMed ID: 36114454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of Tumor Mutation Burden and Immune Cell Infiltration in Thymic Epithelial Tumors.
    Du H; Xie S; Guo W; Zhang W; Che J; Zhu L; Hang J
    Ann Clin Lab Sci; 2021 Jan; 51(1):44-54. PubMed ID: 33653780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors.
    Wang ZM; Xu QR; Kaul D; Ismail M; Badakhshi H
    Thorac Cancer; 2021 Jul; 12(13):1995-2006. PubMed ID: 34033229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.
    Zhang L; Li L; Zhan Y; Wang J; Zhu Z; Zhang X
    Front Oncol; 2020; 10():542140. PubMed ID: 33552945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of breast cancer: a potential novel immune-related lncRNAs signature.
    Lai J; Chen B; Zhang G; Li X; Mok H; Liao N
    J Transl Med; 2020 Nov; 18(1):416. PubMed ID: 33160384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
    Arbour KC; Naidoo J; Steele KE; Ni A; Moreira AL; Rekhtman N; Robbins PB; Karakunnel J; Rimner A; Huang J; Riely GJ; Hellmann MD
    PLoS One; 2017; 12(8):e0182665. PubMed ID: 28771603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and validation of DNA methylation markers for overall survival prognosis in patients with thymic epithelial tumors.
    Li S; Yuan Y; Xiao H; Dai J; Ye Y; Zhang Q; Zhang Z; Jiang Y; Luo J; Hu J; Chen C; Wang G
    Clin Epigenetics; 2019 Mar; 11(1):38. PubMed ID: 30832724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer.
    Wu Y; Zhang L; He S; Guan B; He A; Yang K; Gong Y; Li X; Zhou L
    Aging (Albany NY); 2020 Nov; 12(22):23306-23325. PubMed ID: 33221763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginase Pathway Markers of Immune-Microenvironment in Thymic Epithelial Tumors and Small Cell Lung Cancer.
    Umemura S; Chen V; Chahine JJ; Kallakury B; Zhao X; Lee H; Avantaggiati ML; He Y; Wang C; Giaccone G
    Clin Lung Cancer; 2022 Mar; 23(2):e140-e147. PubMed ID: 34393062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors.
    Yamamoto Y; Iwahori K; Funaki S; Matsumoto M; Hirata M; Yoshida T; Kanzaki R; Kanou T; Ose N; Minami M; Sato E; Kumanogoh A; Shintani Y; Okumura M; Wada H
    Sci Rep; 2020 Mar; 10(1):4064. PubMed ID: 32132638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC00174 is a novel prognostic factor in thymic epithelial tumors involved in cell migration and lipid metabolism.
    Tito C; Ganci F; Sacconi A; Masciarelli S; Fontemaggi G; Pulito C; Gallo E; Laquintana V; Iaiza A; De Angelis L; Benedetti A; Cacciotti J; Miglietta S; Bellenghi M; Carè A; Fatica A; Diso D; Anile M; Petrozza V; Facciolo F; Alessandrini G; Pescarmona E; Venuta F; Marino M; Blandino G; Fazi F
    Cell Death Dis; 2020 Nov; 11(11):959. PubMed ID: 33161413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
    Li L; Xie R; Lu G
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoints related-LncRNAs can identify different subtypes of lung cancer and predict immunotherapy and prognosis.
    Zhang H; Liu M; Du G; Yu B; Ma X; Gui Y; Cao L; Li X; Tan B
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1597-1612. PubMed ID: 35296921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the landscape of immunotherapy in thymic epithelial tumors.
    Maniar R; Loehrer PJ
    Cancer; 2023 Apr; 129(8):1162-1172. PubMed ID: 36808725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.